BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37325629)

  • 21. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytolytic T lymphocyte (CTL) cytosolic alkalinization during CTL-mediated killing.
    Lindquist RR; Howcroft TK
    J Leukoc Biol; 1991 May; 49(5):525. PubMed ID: 2016572
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
    Taffs RE; Redegeld FA; Sitkovsky MV
    J Immunol; 1991 Jul; 147(2):722-8. PubMed ID: 1649222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes.
    Young JD; Liu CC; Persechini PM; Cohn ZA
    Immunol Rev; 1988 Mar; 103():161-202. PubMed ID: 3292393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8
    Uzhachenko RV; Shanker A
    Front Immunol; 2019; 10():1906. PubMed ID: 31456803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
    Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes.
    Kranz DM; Eisen HN
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3375-9. PubMed ID: 2953028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human NK cell-mediated cytotoxicity by exposure to ammonium chloride.
    Brander C; Matter-Reissmann UB; Jones NG; Walker BD; Sachs DH; Seebach JD
    J Immunol Methods; 2001 Jun; 252(1-2):1-14. PubMed ID: 11334960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response.
    Smyth MJ
    Bioessays; 1995 Oct; 17(10):891-8. PubMed ID: 7487970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicity.
    Hiserodt JC
    Adv Exp Med Biol; 1985; 184():139-60. PubMed ID: 2931000
    [No Abstract]   [Full Text] [Related]  

  • 34. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
    Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
    Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell lysis by T cells distinct from NK cells and alloantigen-specific cytotoxic T cells.
    Thiele DL; Lipsky PE
    Clin Immunol Immunopathol; 1988 Dec; 49(3):405-23. PubMed ID: 2461269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirements for CD28-dependent T cell-mediated cytotoxicity.
    Azuma M; Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    Itoh K; Platsoucas CD; Balch CM
    J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Cell-Mediated Immune Function Using the Cytotoxic T-Lymphocyte Assay.
    Burleson GR; Burleson FG; Dietert RR
    Methods Mol Biol; 2018; 1803():199-208. PubMed ID: 29882141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage.
    Zarcone D; Tilden AB; Lane VG; Grossi CE
    Blood; 1989 May; 73(6):1615-21. PubMed ID: 2785411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.